Srinivas Rao, MD, PhDMember of Board of Directors and Series A Investor
Srinivas Rao is the Chief Scientific Officer at ATAI Life Sciences AG and the former CEO of Kyalin Biosciences.
Srinivas Rao has been the Chief Medical Officer of multiple biotech companies, including Axial Biotheraputics, Inc., Deposed, Inc. and Kayla Pharmaceuticals. He holds an MD in Internal Medicine from Yale University School of Medicine and a PhD in Neuropharmacology from Yale University. Srinivas has also been an advisory board member to UCSD SDTA and HUYA Bioscience international.